Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-25 @ 6:58 PM
Study NCT ID:
NCT01723904
Status:
COMPLETED
Last Update Posted:
2014-06-03
First Post:
2012-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease
Sponsor:
UCB BIOSCIENCES GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10
Start Date Type:
None
Primary Completion Date:
2013-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-06
First Submit QC Date:
None
Study First Post Date:
2012-11-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-03-11
Results First Submit QC Date:
None
Results First Post Date:
2014-06-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-07
Last Update Post Date:
2014-06-03
Last Update Post Date Type:
ESTIMATED